CU Medical Systems Inc (115480) Fair Value & Analysis
Healthcare · KR · Market cap 21.5B KRW
Strengths
Risks
Fair value as of: Aug 19, 2026
From 24 valuation models · updated yesterday
Share price +28.4% over the past month.
A strong business, but screening 50% overvalued on our models.
What matters now
- A high-quality business (quality 76/100), yet the market already pays well above fair value. Quality at a full price, with little margin of safety.
- The price sits above even our optimistic bull case (1,418 KRW). The favourable scenario is already priced in.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 19, 2026.
How to read this chart
60‑month range 1,705 KRW – 9,035 KRW · fair‑value band 850.60 KRW – 1,418 KRW · the 2,280 KRW price screens above the 1,134 KRW fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Aug 19, 2026.
Analysis
CU Medical Systems Inc (115480) currently trades at 2,280 KRW, while our model-based Fair Value estimate is 1,134 KRW, implying the stock looks roughly 50.3% overvalued today. The Quality Score stands at 76/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: high).
Over the trailing twelve months, CU Medical Systems Inc generated revenue of 45.0B KRW at a net margin of -6.5%. Revenue grew 56.9% year over year. Net debt stands at 13.7B KRW. Fundamentals as of Aug 19, 2026
Our scenario range runs from 850.60 KRW (bear case) to 1,418 KRW (bull case); at 2,280 KRW, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 31% below its 52-week high and 28% above its 52-week low, currently below its 200-day average. For context, the median of 10 Healthcare peers we cover trades at -10% fair-value upside, at -50%, 115480 screens richer than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 24 models by family
Widest divergence: Growth DCF (9,059 KRW) versus Earnings-Based (338.69 KRW). Highest evidence: Growth DCF (80).
Notify me when 115480 reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Aug 19, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 72 · Market factors (momentum, volatility) 28
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
CU Medical Systems, Inc. manufactures and sells defibrillators worldwide. The company offers automatic external defibrillators (AEDs), mechanical cardiopulmonary resuscitation systems, healthcare and rehabilitation products, AED trainers, and sterilizers/disinfectors. It also resells Apple products, including Mac, iPad, and iPod.
Full company description
CU Medical Systems, Inc. manufactures and sells defibrillators worldwide. The company offers automatic external defibrillators (AEDs), mechanical cardiopulmonary resuscitation systems, healthcare and rehabilitation products, AED trainers, and sterilizers/disinfectors. It also resells Apple products, including Mac, iPad, and iPod. The company was founded in 2001 and is headquartered in Wonju-si, South Korea.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
CU Medical Systems Inc reported revenue of 48.2B KRW in FY2025 versus 35.4B KRW in FY2021, a compound +8.0%/yr. Reported net income was 819M KRW in FY2025.
115480 screens 50% overvalued. Compare with InBody Co →
Peer Group
Health Care · 2314 stocks
How this stock ranks against its sector: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median. (Industry “Healthcare Equipment & Supplies” was too small, so the broader sector is used.)
Valuation Multiples vs Health Care median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
VALUE 0: the price sits above our fair-value range.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Healthcare Equipment & Supplies stocks, each showing price versus our Fair Value estimate (as of Aug 19, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| InBody Co 041830 | 67,400 KRW | 49,984 KRW | -26% |
| i-SENS, Inc 099190 | 18,480 KRW | 8,168 KRW | -56% |
| Value Added Technology Co 043150 | 20,950 KRW | 60,242 KRW | +188% |
| Mediana Co 041920 | 10,070 KRW | 6,289 KRW | -38% |
| Meta Biomed Co 059210 | 3,980 KRW | 9,268 KRW | +133% |
| Sewoon Medical Co 100700 | 2,300 KRW | 6,054 KRW | +163% |
| MEKICS CO., Ltd 058110 | 1,642 KRW | 1,581 KRW | -4% |
| PeopleBio, Inc 304840 | 561.00 KRW | 504.98 KRW | -10% |
| Novartis AG NVSN | 2,742 MXN | 1,952 MXN | -29% |
| Sun Pharmaceutical Industries Limited SUNPHARMA | ₹1,944 | ₹989.50 | -49% |
Compare CU Medical Systems Inc with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Healthcare stocks →
Discover undervalued stocks
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is CU Medical Systems Inc (115480) overvalued or undervalued?
What is the fair value of 115480?
What is the quality score of 115480?
What is the revenue of CU Medical Systems Inc (115480)?
What is the net profit margin of 115480?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track CU Medical Systems Inc and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.